Bios

IDSC brings its clients more than 60 directors that average 25-years of experience in big pharma, biotech, & academia in addition to post career consulting experience.  Our clients receive years of therapeutic area experience and line discipline expertise to drive their programs from early discovery through to market launch in most of the major therapeutic areas.

 

About fifty percent of IDSC's directors are listed on this page.  Click on their links to see their full bios.  For additional information, go to our contacts page and request additional information.

CLICK HERE for Discipline Experts

AJB, PhD (Oncology, Metabolic Diseases):  25 years big pharma, 6 years Academics, 5 yrs biotech; oncology, metabolic disease; medicinal chemistry.  more...

 

DJC, PhD (Oncology):  30 Years big pharma, biotech, academia, consulting, global oncology research ops at Aventis, co-founded Angiogene & licensed lead to AZ, Oncology pharmacology.  more...

 

JD, PhD (Infectious Diseases):  30 years big pharma, global head,  infectious diseases,  med-chem, 30 clinical candidates, 8 compounds to the clinic.  more...

 

SAG, PhD (CNS):  17 years big pharma; CNS; med-chem; outsourcing management, project management; 5 clinical candidates.  more...

 

BAK, PhD (Virology, CNS):  30 years big pharma and consulting, med-chem, virology, CNS, eye diseas, plus broadly other therapeutic areas, 33 issued patents, over 70 publications.  more...

 

JAK, PhD (Cardiovascular, Metabolic Diseases):  30 years big pharma; cardiovascular, metabolic diseases; pharmacology; global therapeutic area head; portfolio management; idea to POC.  more...

 

AMN., MD (Oncology, Immunology):  20 years biotech; immunology, inflammation; phamacology; translational research.  more...

 

RJS, PhD (Cardiovascular, Therapeutics, Devices, Diagnostics):  25 years pharma, VP preclinical research at Afmedica, director of CV therapeutics at Pharmacia, founder & CEO of several biotechs, cardiovascular pharmacology, coagulation.  more...

 

CPT, PhD (CNS):  27 years big pharma; CNS; pharmacology;  neurological disorders, psychiatric disorders, pain; gabapentin, pregabalin.  more...

 

BJZ., PhD (Biologics, Oncology, COPD, CV):  25 years big-pharma, biotech; oncology pharmacology; large and small species; recombinant proteins, monoclonal antibodies, vaccines, and engineered proteins.  more...

Discipline Experts

IRA, MS (Clinical Development, Operations):  Over 30 years big and small pharma, senior management clinical research, clinical operations, strategic planning, protocol developmnet, timeline development, budgets, study initiation & concuct, CRO management.  more...

 

BMC, MS (Regulatory, Clinical Dev., Therapeutics, Devices, Dermatology, Wound Healing, Ophthalmology):  32 years biotech & consulting, proteins, antibodies, small molecules, VP clinical & regulatory affairs at Dow Pharmaceutical Sciences, VP of regulatory, clinical, and quality at Fibrogen, Inc.  more...

 

CGC, PhD (Analytical Development, Formulation, CMC):  26+ years in pharma and chemical industry; Extensive expertise in analytical, formulation R&D, manufacturing, quality assurance/quality control, and regulatory CMC.  more...

 

MSC, PhD (API/CMC):  26 years big pharma; regulatory filings; tech transfer; CMC, and API management.  more...

 

LCC, PhD (Regulatory, Nutraceuticals, Devices, Diagnostics):  20+ years biotech & academia;  multiple VP roles; nutraceuticals, medical foods, devices; neurodegenerative diseases, clinical, regulatory, commercialization strategy.  more...

 

GMF, PhD (Clinical development, CNS):  clinical development program leader and former VP, TA head neurology/psychiatry, 19 NCEs, 11 commercialized products at Novartis and Pfizer.  more...

 

FJK, MS (Clinical Development, Stem Cells, Therapeutics):  26 years big pharma & small biotech, clinical development & corporate strategy, program management, clinical operations, stem cell therapies, CV, CNS, oncology, women’s health, inflammation.  more...

 

BAL, PhD (Small Molecule Formulation, CMC): 35 years big pharma & consulting, ED and VP at BMS, preformulation, liquid, topical, parenteral formulations, drug delivery, multiple TAs, small molecules, early preclinical to phase III. more...

 

DM., PhD (Molecular Modeling):  24 years big pharma; molecular modeling, CNS, cardiovascular, infectious diseases, 3 clinical candidates.  more...

 

RJP, PhD (API Management)  30 years big pharma, API management , process chemistry and manufacturing, andcost analysis, chemical development & API processes, CMO identification and management, small molecules and natural products.

 

BCS., PhD (Analytical, Formulation R&D, CMC):  Over 30 years in big pharma, CRO, and consulting, extensive experience in analytical, formulation R&D, and CMC regulatory.  more...

 

BES, DVM, PhD (Toxicology):   21 years big pharma; toxicology, pathology; study design; IND support.  more...

 

JS, BS (Commercialization):  28 years big pharma, consulting; commercial strategy, product assessment, valuation, lifecycle planning, advisory boards.    more...

 

KS, BS (API Management & CMC; Biologics, Small Molecules):  16 years biotech, cGMP, senior project and operations management, EHS officer, facility management, budget management, IMPD, IND, NDA, MAA.  more...

 

KJT, MD (Clinical, Antibacterials):  26 years big pharma, Internal medicine, clinical trial design, 3 marketed drugs in infectious disease.  more...

 

JWT, PhD (Biologics Formulation):  30 years biotech; biologics; process development, formulation, analytical development, CMC, lyophilization, and stability.  more...

 

HGW, MD (Clinical, Dermatology):  30 years biotech; biologics; process development, formulation, analytical development, CMC, lyophilization, and stability.  more...

 

LRW, PhD (ADME/Clinical Pharmacology):  30 years big pharma, population PK and PK/PD, dose selection, allometric scaling, and modeling and simulation support.  more...

 

JRZ, PhD (API/CMC):  22 years big pharma, 6 years API consultant,  chemical development of API processes, API cost analysis, CMO identification and management.  more...

 

MOZ, MS (Regulatory):  25 years  biotech; SVP; regulatory affairs & strategy;  IND, CTA, INPD, CTD submissions.  more...

Business Development

Print Print | Sitemap
© 2007-2014 IDSC, LLC.